April 14, 2015—BrosMed announced CE Mark and Launch of its Minerva™ percutaneous transluminal angioplasty (PTA) dilatation catheter for the treatment of patients with peripheral arterial disease.
As part of the BrosMed Medical balloon catheter portfolio, this generation, high-performance workhorse 0.018-inch semi-compliance PTA balloon catheter is intended to dilate stenoses in iliac, femoral, iliofemoral, popliteal, infrapopliteal, and renal arteries. It is also indicated for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae and for postdilation of balloon-expandable and self-expanding stents in the peripheral vasculature.
According to the company, the Minerva™ catheter is designed to provide outstanding crossability with a comprehensive selection of balloon sizes on its 0.018-inch over-the-wire platform. The device is available in balloon diameters of 1.5 to 10 mm and lengths of 5 to 200 mm, and the catheter lengths available of 70cm, 90cm and 150cm. Minerva™ combines a state of art engineered balloon technology, superior hydrophilic coating with a low-profile body and unique manicured tip design to enhance crossability and pubshability. Constructed with engineered material, the catheter has consistent rated burst pressures of 14atm from 1.5 to 10mm.
“The launch of Minerva™ PTA balloon dilatation catheter expands our balloon product portfolio from current cardiovascular filed to the endovascular filed. As acknowledged from cardiovascular market, the world smallest PTA balloon size of 1.5x5mm is available for tough and tortious lesion ever treated before.” said by Jos A.W.J de Korte, General Manager of BrosMed Medical B.V., the marketing and sales center of BrosMed Medical in Europe.
Please contact our regional distributors and/or our sales at email@example.com for products details.
About BrosMed Medical
BrosMed Medical is more than just a company; we are leading the medical device design and manufacturing revolution.
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.